Project funded by the European Commission under the Horizon Europe Programme, HORIZON-EIC-2025-PATHFINDEROPEN
Project number: 101257367
Total project value: EUR 2,998,860.00
EU contribution: EUR 2,998,860.00, including: 670 275,00 EUR for PORT
Project duration: 01/05/2026 – 30/04/2030
Project Coordinator (at PORT): Muhammad Danang Birowosuto, PhD
Project consortium:
- Technische Universiteit Delft – Consortium Leader
- Accent Pro 2000 S.R.L. – Consortium Member
- Fondazione Bruno Kessler – Consortium Member
- Sieć Badawcza Łukasiewicz – Port Polski Ośrodek Rozwoju Technologii – Consortium Member
- Université Claude Bernard Lyon 1 – Consortium Member
- Centre national de la recherche scientifique (CNRS) – Consortium Member
Photon-counting computed tomography (PCCT) represents the next major leap in X-ray imaging technology. It enables images with exceptionally high contrast, spatial resolution, and low noise, while reducing radiation dose compared to conventional CT.
A unique advantage of PCCT is its spectral (or “color”) imaging capability, allowing quantitative assessment of tissue composition and contrast agent concentration. Despite its promise, widespread clinical adoption of PCCT remains limited due to the high cost of current scanners and the insufficient accuracy of existing detector technology.
The QuPIX project aims to unlock the full clinical potential of X-ray photon counting by developing a new, affordable, and scalable detector based on quantum-enhanced perovskite scintillators (QuPS) and micro-avalanche photon counters (μAPC). This innovative approach addresses key challenges related to light yield, energy resolution, decay time, and X-ray stopping power, ensuring optimal performance for next-generation imaging systems.
The project will design and validate a laboratory-scale prototype, laying the groundwork for future commercial deployment of QuPIX-based imaging technologies in medical and non-medical markets (such as security screening).
By combining multidisciplinary expertise with breakthrough materials science, QuPIX will revolutionize medical imaging, strengthen Europe’s leadership in PCCT detector technology, and ultimately improve the quality and accessibility of healthcare through faster and more accurate diagnosis.
